Venetoclax-ponatinib for T315I/compound-mutated Ph+ acute lymphoblastic leukemia.
Wang H, Yang C, Shi T, Zhang Y, Qian J, Wang Y, Hu Y, Mao L, Ye X, Liu F, Xi Z, Shou L, Fu C, Naranmandura H, Jin J, Zhu HH.
Wang H, et al. Among authors: yang c.
Blood Cancer J. 2022 Jan 28;12(1):20. doi: 10.1038/s41408-022-00621-9.
Blood Cancer J. 2022.
PMID: 35091541
Free PMC article.
No abstract available.